Agios Pharmaceuticals, Inc.
HealthcareNASDAQ:AGIO · NASDAQ Global Select
+$0.74 today
Vol 1.14M · Avg 1.06M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-14.11%
Period High
$45.49
Period Low
$22.34
Latest
$29.46
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
ImmunityBio, Inc.
NASDAQ:IBRX
$7.44B
Liquidia Corporation
NASDAQ:LQDA
$6.33B
Cogent Biosciences, Inc.
NASDAQ:COGT
$5.66B
Denali Therapeutics Inc.
NASDAQ:DNLI
$3.44B
Beam Therapeutics Inc.
NASDAQ:BEAM
$2.99B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
89bio, Inc.
ETNB
$2.20B
Galapagos N.V.
GLPG
$1.84B
Sarepta Therapeutics, Inc.
NASDAQ:SRPT
$1.62B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.41B
What is the latest AGIO filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does AGIO have?
Intrinsic Alpha currently shows 20 recent filings for AGIO.
Explore More
Continue the stock analysis
Jump to another research area for this company.